Core Insights - The inclusion of "medical beauty services" in the CPI marks a significant shift for the industry, transitioning from a niche service to a recognized component of the national economic monitoring system [3][19] - The implementation of the new VAT regulations explicitly excludes profit-driven medical beauty institutions from tax exemptions, reinforcing their classification as commercial services and eliminating tax arbitrage opportunities [3][19] - These dual policy adjustments signify a transition from "wild growth" to "regulated development," fundamentally restructuring the competitive landscape and development logic of the medical beauty industry [3][19] Market Dynamics - The medical beauty market is experiencing "differentiated growth," with leading chain institutions achieving growth through refined operations, while smaller institutions face significant operational pressures [5][21] - In the first half of 2025, over 63% of medical beauty institutions reported revenue declines, with only 14% achieving growth; Q2 was particularly challenging, with 58% of institutions experiencing declines [5][21] - The average customer spending in the medical beauty industry dropped to 6,500 yuan, a 10% decrease year-on-year, while the frequency of consumer visits increased, indicating a trend towards more conservative spending among middle and high-income consumers [5][21] Consumer Trends - The trend of "popularization and down-market penetration" is becoming increasingly evident, with lower-tier cities emerging as new growth engines for the industry [6][22] - By 2025, the proportion of medical beauty institutions in third-tier cities and below increased from 30% in 2022 to 42%, with overall consumption growth reaching 22%, double that of first-tier cities [6][22] - Non-surgical light medical beauty projects have become the mainstream, accounting for over 53% of the market, with a market size of 227.9 to 258 billion yuan, driving industry growth [6][22] Regulatory Environment - The simultaneous implementation of the CPI inclusion and new VAT regulations represents a policy "one-two punch" for the regulated development of the medical beauty industry, establishing its commercial consumption attributes [8][24] - This regulatory shift has eliminated the "gray area" label that has long plagued the industry, with the CPI now monitoring price fluctuations and consumption scale as part of national economic management [9][25] - The combination of these policies is transforming the identity of the medical beauty industry from "marginal service" to "mainstream consumption," laying the groundwork for its regulated development [10][26] Competitive Landscape - The regulatory changes are leading to a "good money driving out bad money" scenario, where compliant institutions benefit from favorable conditions while non-compliant ones face significant operational challenges [11][27] - Over 18,000 non-compliant institutions were shut down in 2025, and more than 320 violators had their licenses revoked, indicating the effectiveness of ongoing regulatory measures [11][27] - The market is shifting from a seller's market to a buyer's market, with price wars becoming a primary strategy for smaller institutions competing for customers [6][22] Industry Evolution - The medical beauty industry is transitioning from an upstream-dominated model to one focused on terminal capabilities, with an emphasis on differentiation and scale as core competitive advantages [12][28] - Upstream companies are shifting their focus from licensing to product innovation, as competition intensifies and profit margins normalize [13][29] - The entry of public hospitals into the medical beauty sector is becoming a new variable, with a significant increase in the number of public hospitals establishing medical beauty departments [14][30] Consumer Behavior - Consumers are becoming more rational, shifting from a focus on appearance changes to daily anti-aging maintenance, with increased demands for product safety and institutional compliance [15][31] - This rationalization is driving industry upgrades, as institutions move towards standardized solutions that combine products, medical expertise, and post-operative management [15][31] - The transparency of industry information is improving, allowing consumers to compare the overall value of different institutions, which is pushing prices towards greater fairness [15][31]

Summary of the Aesthetic Medicine Industry Conference Call Industry Overview - The aesthetic medicine industry is projected to see a revenue growth of 7% year-on-year in early 2024, with a customer traffic increase of approximately 10%, although the average transaction price is expected to decline by 3%-4% [2][3][21]. - Non-surgical light aesthetic projects account for 70% of the market, with photonic skin treatments making up 45% and non-invasive injection types 25% [2][5]. Key Insights and Arguments - **Product Performance**: - Recombinant collagen products, such as the Jingbo Weimei series, showed significant growth, with a 109% increase in January and an expected 60% in February [2][6]. - New products in the "童颜水光" (youthful water light) category and composite kinetic products also demonstrated strong growth [2][6]. - **Pricing Trends**: - Sales of the Weimei series are increasing, but prices are declining, particularly for the 4 mg model, which has seen a price drop of 30% [2][6]. - The average price decline is attributed to bundled sales strategies, leading to a 20%-30% decrease in average transaction prices [6][7]. - **OEM Collaboration**: - The rise of OEM collaboration is noted, with the group partnering with Jingbo to customize 8 mg products, reducing procurement costs and allowing flexible pricing strategies [2][8]. - The procurement cost for customized products is approximately 700 to 800 yuan, with a retail price set between 8,800 and 8,900 yuan [7][8]. - **Market Dynamics**: - The market is seeing a shift with pharmaceutical companies entering the aesthetic medicine field, leveraging their R&D and branding advantages, but facing challenges in adapting to the fast-changing market and consumer needs [4][15][16]. Additional Important Insights - **Consumer Behavior**: - Customer traffic during the Spring Festival showed a significant increase, particularly in first-tier cities, with some hospitals reporting appointment rates reaching 100% post-holiday [3][4]. - **Product Innovations**: - New products in the youthful water light category are being introduced with lower concentrations to make them more affordable, thus expanding the consumer base [9][10]. - **Future Trends**: - The aesthetic medicine industry is expected to maintain a growth rate of 8%-10% in 2026, driven by the introduction of new technologies and products, despite ongoing regulatory scrutiny [21]. - **Sales Team Effectiveness**: - Companies like Jinbo have developed strong sales teams that maintain good relationships with institutions and media, enhancing their competitive edge [17]. - **Emerging Products**: - The introduction of PDRN materials is anticipated to create a market potential of around 5 billion yuan, with several companies, including Lepu, working towards obtaining necessary certifications [20][21]. This summary encapsulates the key points discussed in the conference call regarding the aesthetic medicine industry, highlighting growth trends, pricing strategies, and market dynamics.

国家卫生健康委昨日明确，"轻医美"属于医疗行为，严禁生活美容机构违规开展。当前一些商家利 用"容貌焦虑"非法培训、无证操作，导致伤害事件频发。公众应选择正规医疗机构，警惕"速成班"话 术，发现线索可举报。 爱美之心碰上美丽陷阱 究竟什么才是"轻医美"？国家卫健委给出了清晰界定：它本质是医疗行为。所谓"轻医美"，通常指利用 注射、光电、生物技术等方式进行的非手术类医疗美容项目，其核心前提是必须在取得《医疗机构执业 许可证》的医疗美容机构内开展，且操作者必须是持有相关资质的专业医师或护士。这意味着，我们日 常生活中熟悉的美容院、美发店、美甲店、养生会所等生活类美容机构，其服务范围仅限于皮肤表面清 洁、护理、修饰等非侵入性项目，严禁开展任何破皮、注入或使用医疗器械的"轻医美"项目。 公众切勿因价格诱惑或熟人介绍，而在这些场所接受所谓的"轻医美"服务，将自身健康置于巨大风险之 中。 别让速成班毁了你的脸 想要悄悄变美，却可能踏入危险陷阱。近年来，打着"无创""恢复快"招牌的"轻医美"项目风靡大街小 巷，从热玛吉、水光针到少女针，吸引着众多求美者。然而，这股热潮背后却乱象丛生。 国家卫生健康委在昨天召开的新闻发布会上指 ...

二，炉边漫谈 毫无疑问，上周五美国财政部长对于美联储降息缩表的一番解释，大大缓解了市场的焦虑，而这也是今天全球股市暴涨的原因所在，那么这段话究竟是什么 意思呢？ 先说说「美联储的定心丸」：别慌，不会急着缩表 一，今日要点 今天沪指上演红周一，蛇年股市还有最后四个交易日，是否就此开启春节红包行情呢？ 最近市场不是揪着美联储换主席的事儿焦虑嘛？担心沃什上台后会不会「政策急转弯」、急着缩表抽流动性。结果美国财长贝森特出来「灭火」了：就算沃 什当主席（这家伙之前还批评过美联储买债券呢），也不会马上动手缩表；而且沃什会很独立，美联储可能得花一整年才会决定资产负债表的事儿。 其实市场怕的就是「突然收紧」——毕竟缩表意味着流动性变少，资金成本会涨。贝森特这话本质是安抚情绪，但说到底，美联储真要怎么做，还是得看资 金怎么解读：要是资金觉得「缩表节奏慢」，就敢放心进场；要是觉得「口说无凭」，照样会用脚投票。 再聊聊「特斯拉的光伏野心」：中国产业链要吃肉了 特斯拉又搞大动作——要扩大太阳能电池制造，三年目标冲100吉瓦！更关键的是：全球光伏产业链中国占绝对优势，马斯克就算想搞「太空光伏」（航 天、太空算力的能源核心），也绕不开中 ...

Core Viewpoint - The increasing popularity of aesthetic medical procedures among older adults, particularly women over 50, is notable as they seek to enhance their appearance before the upcoming Spring Festival [2][3]. Group 1: Trends in Aesthetic Medicine - There is a significant rise in older individuals seeking aesthetic treatments, with many coming in groups for consultations [2]. - The trend indicates that beauty is no longer seen as exclusive to younger individuals, with older women actively participating in aesthetic procedures [2][3]. Group 2: Safety and Rationality in Aesthetic Procedures - Health and safety should be prioritized in aesthetic medicine, with a focus on long-term improvements rather than quick fixes [1][4]. - Patients, especially older ones, are advised to have realistic expectations and avoid excessive procedures that may lead to complications [3][4]. Group 3: Popular Treatments and Recommendations - Non-invasive procedures such as photorejuvenation and laser treatments are gaining popularity, especially before the holiday season [4][5]. - It is recommended to allow sufficient recovery time before engaging in aesthetic treatments, particularly before sun exposure [4][6]. Group 4: Maintenance and Long-term Care - Regular maintenance and healthy lifestyle choices are essential for sustaining the effects of aesthetic treatments [4][6]. - The industry emphasizes a balanced approach to beauty, advocating for gradual and natural enhancements rather than drastic changes [3][4].

Core Viewpoint - The article discusses the increasing popularity of cosmetic procedures among older adults, particularly as the Chinese New Year approaches, emphasizing the importance of safety and health in aesthetic pursuits [1][3]. Group 1: Trends in Cosmetic Procedures - There is a notable rise in older individuals, particularly those over 50, seeking cosmetic enhancements, often accompanied by friends or family [3][4]. - Popular procedures include minimally invasive options like facial lifts and eyelid rejuvenation, which not only improve appearance but also enhance quality of life [4][5]. - Non-surgical treatments such as injectables and light therapy are gaining traction, especially before festive seasons, due to their quick recovery times [7][9]. Group 2: Safety and Professional Guidance - Medical professionals stress the importance of prioritizing health and safety over aesthetic desires, advising against unrealistic expectations and excessive procedures [5][9]. - There are warnings about the risks associated with unregulated cosmetic practices, including severe skin damage from improper use of home beauty devices [9][10]. - Patients are encouraged to maintain realistic expectations and to consider long-term skincare and health habits rather than seeking immediate results through multiple procedures [10][11]. Group 3: Recommendations for Aesthetic Treatments - It is advised that individuals plan for recovery time when scheduling cosmetic procedures, especially before events like travel [9][10]. - The article highlights the importance of individualized treatment plans for issues like pigmentation, emphasizing that not all skin concerns can be resolved with a single treatment [7][9]. - Professionals recommend a balanced approach to cosmetic enhancements, suggesting that less frequent treatments may yield better long-term results [10][11].

Core Insights - The high-net-worth female social circle in first-tier cities in China is undergoing a significant transformation, moving from a restrained "quiet luxury" to a more vibrant and expressive culture driven by pop concerts and celebrity fandom [1][3][13] Group 1: Consumer Behavior - High-net-worth women are engaging in extravagant spending not just for tickets but for a sense of vitality and youthfulness, reflecting a deep psychological need for self-expression and liberation [3][4] - These women, often decision-makers in their professional lives and caretakers at home, are seeking experiences that allow them to break free from their structured lives, leading to a surge in unconventional consumer behavior [5][6] Group 2: Economic Impact - The spending patterns of these women extend beyond ticket purchases, influencing various sectors such as travel, hospitality, and luxury goods, creating a "super leverage" effect on local economies during concert tours [6][8] - The demand for high-end services, including luxury accommodations and fine dining, is significantly boosted by their concert attendance, marking a shift in tourism dynamics towards high-value experiences [6][8] Group 3: Social Dynamics - Concerts are becoming new social venues, replacing traditional settings like golf courses for networking and relationship building, with shared experiences fostering deeper emotional connections [9][11] - The phenomenon of fandom is also serving as a bridge in family dynamics, particularly for mothers navigating relationships with their teenage children, as shared interests in pop culture help dissolve generational gaps [11][12] Group 4: Market Opportunities - The beauty and fashion industries are capitalizing on this trend, with brands targeting these women through collaborations with popular idols, as purchases are not just about products but also about the psychological affirmation of youth and vitality [8][10] - Companies that can resonate with this demographic's desire for excitement and engagement are positioned to capture significant market share, as these women represent a lucrative consumer base [13]

Core Viewpoint - The era of upstream medical beauty supply chain manufacturers relying solely on price control to maintain high profits may be coming to an end, indicating a significant shift in the industry's development logic [2][4]. Group 1: Industry Dynamics - New Oxygen has reached cooperation agreements with 14 upstream manufacturers, including major players like Allergan and Huaxi Biological, marking a pause in the pricing power battle that dominated the previous year [3]. - The medical beauty industry is experiencing a restructuring of power dynamics between upstream and downstream players, suggesting a transformation in the overall industry landscape [4]. Group 2: Pricing Strategies - New Oxygen's founder, Jin Xing, aims to lower the prices of medical beauty projects, citing high operational costs and supplier pricing as key factors for the inflated prices in China compared to countries like South Korea [6]. - The introduction of the "Miracle Tongyan 1.0" project by New Oxygen, priced at 4,999 yuan per unit, significantly undercuts the traditional market price of over 10,000 yuan, leading to backlash from suppliers [6][7]. - The pricing strategy continued to evolve with the launch of "Miracle Tongyan 3.0," which further reduced the price to 2,999 yuan, setting a new low in the industry [7]. Group 3: Supplier Relationships - Despite previous conflicts, some suppliers have reconciled with New Oxygen, indicating a shift in relationships as the market dynamics change [9]. - New Oxygen's purchasing power has increased, allowing it to negotiate better prices with suppliers, as it has established a significant presence with 50 stores across 16 cities by the end of 2025 [11]. Group 4: Market Supply and Demand - The balance of pricing power is shifting towards buyers, with an increase in the number of suppliers and products available, leading to a more competitive market environment [11][14]. - The regulatory environment is improving, with a significant increase in the number of medical beauty device registrations, which is expected to further enhance supply [13]. Group 5: Future Outlook - The medical beauty industry is transitioning from a phase of rapid, unregulated growth to a more structured and value-focused era, emphasizing the importance of quality over price competition [14][16]. - New Oxygen faces challenges in maintaining its scale while achieving profitability and balancing relationships with suppliers, which will be crucial for its successful transformation [15].

Core Viewpoint - The Chinese medical beauty industry is transitioning from chaotic growth to a more regulated, rational, and value-focused era [1][11] Group 1: Industry Dynamics - The era of upstream medical beauty suppliers relying solely on price control to maintain high profits is likely over, as evidenced by recent collaborations between New Oxygen and 14 upstream manufacturers [2] - The pricing power dynamics within the industry are shifting, with New Oxygen gaining leverage to negotiate prices due to its expanding network of stores [7] - The rapid development of the medical beauty industry has led to improved policy approval efficiency, resulting in a significant increase in the number of approved products [9] Group 2: Pricing Strategies - New Oxygen's founder, Jin Xing, aims to lower the prices of medical beauty projects, challenging the traditional high-price system that has persisted in the industry [3] - The introduction of New Oxygen's "Miracle Youth Needle" project at a price of 4,999 yuan per unit significantly undercuts the established market price, leading to backlash from suppliers [4] - The company has continued to innovate with pricing strategies, launching further iterations of its youth needle products at even lower prices, such as 2,999 yuan and 999 yuan [4] Group 3: Supplier Relationships - Despite previous conflicts, some brands that had publicly opposed New Oxygen have recently reconciled and entered into partnerships, indicating a shift in industry relationships [5] - New Oxygen's purchasing volume has reached significant levels, with some suppliers relying on the company for a substantial portion of their sales, fostering stable partnerships [9] Group 4: Future Outlook - The medical beauty industry is moving towards a model that emphasizes value over price competition, as the previous pricing wars have disrupted the long-standing pricing power of upstream manufacturers [10] - New Oxygen plans to expand its store presence significantly in key cities, aiming for a total of at least 35 new stores in 2026 [8] - The company remains optimistic about the future, believing that increased supply and improved technology will lead to more affordable services for consumers [8]

Core Viewpoint - The collaboration between medical beauty brands and "villains" signifies a shift in brand communication, aiming to inject confidence and vitality into the traditionally anxiety-ridden medical beauty marketing landscape [4][6]. Group 1: Industry Overview - The medical beauty industry in China has been characterized by a scarcity of quality and affordable services, leading to information asymmetry and regulatory gray areas that complicate consumer decision-making [9][10]. - Traditional medical beauty institutions often struggle with scalability, as many have been operating for over twenty years with limited store counts, typically between 20 to 40 [6][10]. - The industry is transitioning from a seller's market to a buyer's market due to an increase in product approvals, which is expected to enhance competition and reduce product scarcity [11][12]. Group 2: Company Development - New Oxygen has opened 50 direct-operated clinics across 16 cities and completed over 1 million treatments, positioning itself as a leader in the light medical beauty chain brand sector in China [5][4]. - The company has established the "Youth Selection Alliance," which sets stringent standards for product quality and aims to redefine what constitutes a "good product" in the market [15][16]. - New Oxygen's approach includes a focus on building a scalable and high-quality delivery system to address the industry's challenges of trust and efficiency [7][12]. Group 3: Supply Chain and Market Dynamics - The "Youth Selection Alliance" allows New Oxygen to leverage its treatment volume to negotiate better terms with suppliers, ensuring high-quality products are available to consumers [16][18]. - The company has formed partnerships with major pharmaceutical and medical beauty suppliers, significantly increasing its purchasing power and market influence [17][18]. - New Oxygen's strategy emphasizes the importance of a robust supply chain and efficient distribution channels, which are critical for driving down costs and enhancing product availability [20][21]. Group 4: Future Outlook - The transformation within the medical beauty industry is expected to lead to a healthier ecosystem and a more rational consumer market, characterized by increased choice, transparency, and trust [27][28]. - As the industry moves towards full market competition, companies that can effectively balance consumer trust and supply chain efficiency will thrive [27][28]. - New Oxygen's ongoing efforts to integrate technology and streamline operations are essential for overcoming existing industry challenges and achieving sustainable growth [22][28].